Take a look at some of Tuesday’s morning movers:
Vivus - The Food and Drug Administration will take three more months to make an approval decision for the company’s obesity drug Qnexa. That delay may also weigh on shares of Arena Pharmaceuticals and Orexigen , which have competing obesity treatments in the pipeline.
Toll Brothers, PulteGroup - Goldman Sachs is recommending clients buy shares of the two high-end homebuilders, after an internal survey showed wealthier consumers more confident about the economy and home prices versus six months ago.
Harley-Davidson - Citi has upgraded the motorcycle maker's stock to "buy" from "neutral," saying its dealer checks show solid sales momentum.
Supervalu - The grocery store operator earned 38 cents a share for its fourth quarter, excuding certain items, three cents above estimates. It also projects fiscal 2013 EPS of $1.27 - $1.42 per share, above estimates of $1.19.
Corning, Becton Dickinson - Corning is buying a majority stake in Becton's Discovery Labware unit for $730 million in cash. The unit specializes in drug discovery technology.
X-Rite - The maker of color-measurement systems is being bought by Danaher for $5.55 a share, 39 percent above Monday's closing price for X-Rite.
YPF - Reports out of Spain say China's CNOOC may seek to buy YPF, Argentina's biggest energy producer, for $30 a share.Page 1 of 3 | Next Page